Trailing-twelve-month (TTM) revenue is $91.84 Million with a year-over-year growth of +7.70%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q4 FY2025Period ended 2025-08-31 | $22,315,452 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-20 |
| Q1 FY2026Period ended 2025-11-30 | $23,308,881 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-01-08 |
| Q2 FY2026Period ended 2026-02-28 | $21,996,785 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-09 |
| Q3 FY2026Period ended 2026-05-31 | $24,215,662 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-09 |
| TTM revenue | $91,836,780 |
Current P/S: $73,367,474 market capitalization ÷ $91,836,780 TTM revenue = 0.80x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:19:07.000Z. Latest revenue period ended 2026-05-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q3 FY2026 (2026-05-31): $24.22M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:43:40.557Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-08-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-08-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-08-31 · USD | FY20192019-08-31 · USD | FY20202020-08-31 · USD | FY20212021-08-31 · USD | FY20222022-08-31 · USD | FY20252025-08-31 · USD |
|---|---|---|---|---|---|---|
| NaturTec | $10M | $18M | $13M | $11M | $17M | $22M |
| ZERUST | $41M | $38M | $34M | $46M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-08-31 · USD | FY20192019-08-31 · USD | FY20202020-08-31 · USD | FY20212021-08-31 · USD | FY20222022-08-31 · USD | FY20252025-08-31 · USD |
|---|---|---|---|---|---|---|
| BRAZIL | $3M | $3M | $3M | $4M | $5M | $7M |
| CHINA | $13M | $13M | $13M | $17M |
$91.84M
$91.84 Million
+7.70%
vs. $85.27M a year ago (TTM)
+12.48%
5 Year compound annual growth rate
1 Year
+7.70%
3 Year
+4.95%
5 Year
+12.48%
10 Year
+11.29%
15 Year
+10.87%
20 Year
+9.02%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $84.23M | ($825,043) | (0.97%) |
| 2024 | $85.06M | +$5.16M | +6.45% |
| 2023 | $79.90M | +$5.74M | +7.75% |
| 2022 | $74.16M | +$17.67M | +31.27% |
| 2021 | $56.49M | +$8.86M | +18.59% |
| 2020 |
TTM Growth
+7.70%
3-Year CAGR
+4.95%
5-Year CAGR
+12.48%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:43:40.557Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $62M |
| $16M |
| INDIA | $3M | $8M | $6M | $5M | $19M | $23M |
|---|
| Other Countries | $7M | $7M | $6M | $8M | $9M | $9M |
|---|
| UNITED STATES | $25M | $25M | $20M | $22M | $25M | $30M |
|---|
| $47.64M |
| ($8.11M) |
| (14.55%) |
| 2019 | $55.75M | +$4.33M | +8.41% |
| 2018 | $51.42M | +$11.86M | +29.96% |
| 2017 | $39.57M | +$6.64M | +20.15% |
| 2016 | $32.93M | +$2.61M | +8.61% |
